Who should attend?
ERBI's Annual BioPartnering Exchange is the most successful regional biotechnology event in the UK.
Now into its 8th year, this gathering of leading biotech opinion formers has become a major highlight in the European conference calendar.
What's different about ERBI's event?
Our meeting is a showcase of the leading products, services and technologies that are being researched and developed in a single biotech cluster and because Cambridge is the leading cluster in Europe, this is no ordinary showcase! The event therefore attracts decision makers from global pharma and big biotech - executives keen to get first sight of the latest developments from Cambridge.
We deliberately keep the ERBI event small in terms of numbers of delegates - typically no more than 450 in total. This provides an environment conducive to informal networking (you'll never have the problem of not being able to find someone!) and it means we maintain the quality of the event in terms of the type of company attending (we focus on the bio-pharma companies) in addition to the seniority of delegate.
The format
The event is held over three days during the second week of May and has two main
elements; conference and partnering.
The conference element includes 3-4 keynote speeches by respected biotech influencers
on topical issues and over 25 company presentations by Cambridge companies.
The partnering element, held throughout the event, with day 3 dedicated to
meetings, offers delegates the chance to attend pre-booked, validated one-to-one
meetings.
Delegate feedback
"The conference is really well organised and has been a huge success.
The presentations were interesting and relevant and there is a great opportunity
to meet people from all walks of the UK biotech scene"
Dr Malcolm Skingle, GlaxoSmithKline
"The success of this event says a huge amount about the strength of ERBI and
the East of England in this field"
Professor Trevor Jones - Chairman ABPI
|